ArticleAntibodies (Basel, Switzerland)2025

Immunogenicity Risk Assessment of Biotherapeutics Using an Ex Vivo B Cell Assay.

Kevin M Budge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.